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Diversity of HLA class i and class 
ii blocks and conserved extended 
haplotypes in Lacandon Mayans
Rodrigo Barquera  1,2,18, Joaquin Zuniga  3,4,18, José flores-Rivera5,18, Teresa corona  5,18,  
Bridget S. penman6,18, Diana Iraíz Hernández-Zaragoza2,7,18, Manuel Soler8,18, 
Letisia Jonapá-Gómez9, Kalyan C. Mallempati10,11, Petra Yescas12, Adriana ochoa-Morales12, 
Konstantinos Barsakis10,13, José Artemio Aguilar-Vázquez14, Maricela García-Lechuga8, 
Michael Mindrinos15, María Yunis16, Luis Jiménez-Alvarez3, Lourdes Mena-Hernández8, 
esteban ortega17, Alfredo cruz-Lagunas  3, Víctor Hugo tovar-Méndez8, Julio Granados8*, 
Marcelo fernández-Viña13* & edmond Yunis16*
Here we studied HLA blocks and haplotypes in a group of 218 Lacandon Maya Native American using a 
high-resolution next generation sequencing (nGS) method. We assessed the genetic diversity of HLA 
class I and class II in this population, and determined the most probable ancestry of Lacandon Maya 
HLA class I and class II haplotypes. Importantly, this Native American group showed a high degree 
of both HLA homozygosity and linkage disequilibrium across the HLA region and also lower class II 
HLA allelic diversity than most previously reported populations (including other native American 
groups). Distinctive alleles present in the Lacandon population include HLA-A*24:14 and HLA-B*40:08. 
Furthermore, in Lacandons we observed a high frequency of haplotypes containing the allele HLA-
DRB1*04:11, a relatively frequent allele in comparison with other neighboring indigenous groups. The 
specific demographic history of the Lacandon population including inbreeding, as well as pathogen 
selection, may have elevated the frequencies of a small number of HLA class II alleles and DNA blocks. 
To assess the possible role of different selective pressures in determining Native American HLA 
diversity, we evaluated the relationship between genetic diversity at HLA-A, HLA-B and HLA-DRB1 
and pathogen richness for a global dataset and for native American populations alone. in keeping with 
previous studies of such relationships we included distance from Africa as a covariate. After correction 
for multiple comparisons we did not find any significant relationship between pathogen diversity and 
HLA genetic diversity (as measured by polymorphism information content) in either our global dataset 
or the native American subset of the dataset. We found the expected negative relationship between 
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genetic diversity and distance from Africa in the global dataset, but no relationship between HLA 
genetic diversity and distance from Africa when native American populations were considered alone.
The human major histocompatibility complex (MHC) is located within chromosomal region 6p21.3 and spans at 
least 3.4 Mb of DNA containing more than 400 genes. Human leukocyte antigen (HLA) loci are mapped within 
the MHC region as well as other immune related genes and pseudogenes1. The genetic diversity of MHC genes 
results from selective pressures including functional adaptation to pathogens2–8 with some peptide-HLA com-
plexes being more effective in eliciting an immune response than others4. It seems likely that individuals with 
greater diversity at their HLA loci would have a greater chance of survival in pathogen-enriched environments5, 
but there is debate as to whether simple heterozygote advantage or more complex host-pathogen co-evolutionary 
processes are responsible for the diversity of human HLA alleles generally9–15. In addition to their direct role in 
immune responses against pathogens, HLA molecules are crucial genetic markers to study the genetic diversity 
of populations in the context of disease susceptibility and allotransplantation3–5,16–20.
One of the most important characteristics of the MHC region is a high degree of non-random associations 
between inherited alleles, known as linkage disequilibrium (LD)21,22. Extensive studies in different populations 
have described the existence of extended haplotypes or blocks and other relatively fixed genetic fragments within 
the human MHC17,23. Specific DNA blocks containing two or more MHC loci are often haplospecific for par-
ticular conserved extended haplotypes (CEHs)17. The frequency of CEHs and specific block combinations varies 
between major ancestral groups and/or in different continental populations, and these variations in the frequency 
of CEHs and blocks can be used as measurements of genetic diversity of the MHC17,18,23. It has further been 
suggested that a specific form of linkage disequilibrium - non-overlapping combinations between physically sep-
arate HLA loci - could be a signal of pathogen selection within HLA system24. Assessing the presence of such 
non-overlapping associations thus arises as a possibility to assess pathogen driven selection imprinted in the 
genetic structure of HLA system within populations.
Several studies have described HLA class I and class II alleles and haplotypes in different Native American 
groups from Mexico25–32 and Latin America33–36, including Lacandons37. The study of HLA diversity in Native 
Americans is relevant because evidence suggests that balancing selection at different HLA loci may be involved in 
the prevalence of inflammatory or infectious diseases in these populations38–43. Also, numerous examples of novel 
alleles have been reported in Native Americans44–46, suggesting that pathogen-driven selection of new mutations 
could be critical in the adaptation to endemic pathogens, particularly after migration4,5.
Previous studies of the Lacandon population of Chiapas State have described the genetic variability of low res-
olution HLA class II37, blood groups47 and single nucleotide polymorphisms (SNPs) of Cytochrome P450 2D648. 
Individuals from the Lacandon population were also included in a study of genomic variation across Mexico49. 
However, no studies have been published about the immunogenetic diversity and the possible ancestral origin of 
HLA conserved extended haplotypes (CEH) in a representative group of Lacandon Maya.
The Lacandon or Hach Winik (“the real people”) are descendants of ancient Mayan civilizations, which have 
been considered to have reached their cultural apex in Mesoamerica c. AD 80050,51. Their settlements are mainly 
distributed in the Lacandon Jungle (Fig. 1), which stretches from the State of Chiapas, Mexico, into Guatemala 
and into the southern part of the Yucatán Peninsula52,53. The historical landscape of Lacandon Maya includes 
multiple genocides related with Spaniard conquest, land disputes as well as novel infections such as smallpox, 
Figure 1. Locations where the samples were obtained in Chiapas, Mexico. The communities where the samples 
were taken are represented by a star.
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yellow fever and influenza, and a high degree of inbreeding that has resulted in high prevalence of certain genetic 
conditions, including albinism51,54,55.
The aim of this study is to analyze the immunogenetic diversity and the ancestral origin of HLA CEH in 
Lacandon Maya using next generation high-resolution HLA typing methods, and to use such information to 
assess if there are signatures of evolutionary forces modifying the expected diversity within the HLA system. We 
also assess whether a correlation exists between the genetic diversity (as measured by the polymorphism inform-
ative content, PIC) at class I (HLA-A, -B) and class II (-DRB1) loci in Native Americans (including Lacandon 
Mayans) and a) pathogen and viral richness, and b) the geographic distance from Africa.
Results
HLA allele and haplotype frequencies within the Lacandon population. HLA allele frequen-
cies were obtained by analyzing 458 haplotypes from 229 non-first degree related Lacandon Maya individu-
als genotyped by next generation sequencing (NGS) technologies. Complete haplotypes could be obtained 
for 218 individuals for a total of 436 haplotypes. The most frequent class I haplotypes, all with haplotypic fre-
quencies (H.F.) higher than 5% were HLA-A*31:01~B*40:02~C*03:04 [Native American Most probable 
ancestry (MPA)], A*02:06~B*35:01~C*07:02 (Native American MPA), A*68:03~B*35:01~C*07:02 (Not pre-
viously reported), A*24:02~B*35:12~C*04:01 (Native American MPA), A*68:01~B*40:08~C*03:04 (previous 
reports only include mixed-ancestry populations), A*68:03~B*39:05~C*07:02 (previous reports only include 
mixed-ancestry populations), and A*68:03~B*39:05~C*07:02 (previous reports only include mixed-ancestry 
populations). Only two HLA-A~B~C~DRB1~DRB3/4/5~DQB1~DQA1~DPA1~DPB1 haplotypes exhibited 
frequencies greater that 5%: A*31:01~B*40:02~C*03:04-DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03
:01~DPA1*01:03~DPB1*04:02 (H.F. = 0.0633) a nd A *3 1:01~B*40:02~C*03:04~DRB1*04:11~DRB4*01:01~
DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 (H.F. = 0.0502). These two high frequency haplotypes 
differ only in their HLA-DRB4 allele. The complete frequencies of HLA-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, 
-DQB1, -DPA1, and -DPB1 alleles in Lacandon Maya individuals are detailed in Table 1 (class I) and Table 2 
(class II). HLA-B~C blocks present in Lacandon Maya are listed in Table 3, while the extension of the HLA-
B~C block to the HLA-A gene is provided in Supplementary Table 2. HLA class II haplotypic diversity (HLA-
DRB1~DRB3/4/5~DQA1~DQB1~DPA1~DPB1) is listed in Table 4. The CEHs in Lacandons are listed in Table 5 
and their extension to HLA-A is shown in Table 6. Table 7 shows the complete class I/class II haplotypes for our 
Lacandon Mayans sample. Aggregate block frequency (ABF) for each ancestry can be found in Tables 3 to 6. The 
calculation of ABF is a previously reported and validated approach to estimate the diversity and contribution of 
precisely described HLA blocks of specific ancestries17,56.
Diversity of Lacandon HLA alleles. Forensic parameters of genetic diversity were calculated to assess 
HLA diversity in Lacandon using polymorphism information content (PIC), power of discrimination (PD), and 
Hardy-Weinberg equilibrium (HWE) (Table 8). In this regard, HLA-A, HLA-B and HLA-DRB1 were the most 
polymorphic loci with PIC values of 0.8444, 0.8227 and 0.7555 respectively; whereas HLA-DPB1 and HLA-DPA1 
were the less diverse HLA loci with PIC values of 0.3547 and 0.1581, respectively. A significantly (p < 0.05) lower 
observed heterozygosity (OH) than expected heterozygosity (EH) was observed for HLA-B, HLA-C, HLA-DRB1, 
HLA-DRB3/4/5, HLA-DQA1, and HLA-DQB1 loci. In contrast, HLA-A locus exhibited a higher OH than EH 
value (p < 0.0001).
Genetic similarities with other populations. A PCA plot and a population phylogenetic tree were con-
structed using 180 populations (including the Lacandon group studied in this work) with HLA-A, HLA-B and 
HLA-DRB1 data from a worldwide population dataset. Figure 2 and Supplementary Fig. 1 illustrate the results 
of the Principal Components Analysis (PCA). The Lacandon Mayans (purple star) cluster together with other 
Mexican Native American and Mexican Admixed populations, including Mayans from Guatemala. In addition, a 
Neighbor-Joining (NJ) analysis (Fig. 3) revealed that Lacandon Mayans are more closely related to Mixe, Mixtec 
and Zapotec Mexican Native American populations, which are geographically speaking the closest ones to the 
Lacandon Mayans. It is interesting to note that using HLA genes as genetic estimators, it is possible to mimic the 
results (although not to the same resolution) obtained with genome-wide data49.
non-overlapping associations between HLA alleles. Plots of the frequencies of all possible HLA-A~B, 
HLA-B~C and HLA-B~DRB1 allele combinations are shown in Fig. 4, and plots for all HLA class I and class II 
associations can be found in Supplementary Fig. 3. Visual inspection suggests a high degree of non-overlap 
between HLA-B and -C in particular. Figure 5 displays the ⁎fadj metric (a parameter used to rank the strength of 
non-overlapping associations between different pairs of HLA loci) for all possible pairwise combinations of HLA 
loci with HLA-A (4a), with HLA-B (4b) and with HLA-DRB1 (4c), showing also the distribution of ⁎fadj values 
obtained when the alleles at the relevant loci are randomized (retaining their population frequencies within the 
dataset). The heatmap in Fig. 4 (4d) illustrates how many standard deviations above the mean randomized ⁎fadj 
value the actual Lacandon ⁎fadj value is for each indicated pair of loci. HLA-B and -C exhibit the highest degree of 
non-overlap by this measure, followed by HLA-A and -B, HLA-DRB1 and HLA-DRB3/4/5, HLA-A and -C, and 
HLA-DRB3/4/5 and HLA-DQA1. All ⁎fadj values for each pair of HLA loci in the dataset are displayed in 
Supplementary Table 4.
Assessment of the correlation between pathogen richness and HLA diversity. We calculated 
PIC values for 122 populations as an estimator of genetic diversity for HLA-A, HLA-B and HLA- DRB1 high 
resolution data (see Supplementary Table 1). We extracted pathogen and viral richness data from the GIDEON 
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HLA-A 
protein HLA-A allele A.F.
HLA-B 
protein HLA-B allele A.F. HLA-C protein HLA-C allele A.F.
A*24:02 0.1904 B*40:02 0.2638 C*07:02 0.3784
A*24:02:01:01 0.1790 B*40:02:01 0.2764 C*07:02:01:01 0.3732
A*24:02:01:02 L 0.0023 B*35:01 0.2156 C*07:02:01:03 0.0052
A*31:01 0.1697 B*35:01:01:02 0.2133 C*03:04 0.2798
A*31:01:02:01 0.1651 B*39:05 0.1651 C*03:04:01:01 0.0677
A*31:01:13 0.0046 B*39:05:01 0.1562 C*03:04:01:02 0.2083
A*68:01 0.1445 B*35:12 0.1101 C*04:01*** 0.1789
A*68:01:02 0.0046 B*35:12:01 0.1101 C*04:01:01:01 0.1789
A*68:01:02:01 0.1359 B*40:08 0.0665 C*15:02*** 0.0436
A*02:06 0.1399 B*40:08 0.0459 C*15:02:01:01 0.0046
A*02:06:01:01 0.1157 B*18:01 0.0275 C*15:02:01:02 0.0390
A*68:03 0.1376 B*18:01:01:01 0.0023 C*07:01 0.0344
A*68:03:01 0.1070 B*18:01:01:02 0.0252 C*07:01:01:01 0.0321
A*02:01 0.0940 B*52:01*** 0.0161 C*07:01:02 0.0023
A*02:01:01:01 0.0764 B*52:01:02 0.0153 C*03:05 0.0183
A*24:14 0.0550 B*39:01 0.0138 C*01:02 0.0161
A*68:05 0.0275 B*39:06 0.0138 C*01:02:01 0.0046
A*29:02 0.0115 B*39:06:02 0.0138 C*03:03 0.0115
A*29:02:01:01 0.0115 B*39:08 0.0138 C*03:03:01 0.0104
A*03:01 0.0069 B*39:08 0.0138 C*16:01 0.0115
A*03:01:01:01 0.0069 B*44:03*** 0.0115 C*16:01:01:01 0.0069
A*33:01 0.0046 B*44:03:01:01 0.0115 C*08:02 0.0092
A*33:01:01 0.0023 B*35:43 0.0115 C*08:02:01:01 0.0023
A*30:01 0.0046 B*35:43:01 0.0069 C*15:04*** 0.0046
A*30:01:01 0.0046 B*14:02 0.0092 C*15:04:01 0.0046
A*68:02 0.0046 B*14:02:01:01 0.0023 C*05:01*** 0.0023
A*68:02:01:01 0.0046 B*14:02:02 0.0046 C*05:01:01:02 0.0023
A*01:01 0.0023 B*51:01*** 0.0092 C*06:02*** 0.0023
A*26:01 0.0023 B*51:01:01:01 0.0092 C*06:02:01:01 0.0023
A*26:01:01:01 0.0023 B*07:02 0.0069 C*08:01 0.0023
A*30:02 0.0023 B*07:02:01 0.0069 C*08:01:01 0.0023
A*30:02:01:01 0.0023 B*35:17 0.0069 C*12:02 0.0023
A*33:03 A*33:03:01 0.0023 B*35:17:01 0.0069 C*15:15*** 0.0023
B*49:01*** 0.0069 C*17:01*** 0.0023
B*49:01:01 0.0069 C*17:01:01:02 0.0023
B*35:08 0.0046
B*35:08:01 0.0046
B*39:02 0.0046
B*39:02:02 0.0046
B*40:11 0.0046
B*40:11:01 0.0046
B*53:01*** 0.0046
B*53:01:01 0.0046
B*13:02*** 0.0023
B*13:02:01 0.0023
B*35:14 0.0023
B*35:14:01 0.0023
B*39:39 0.0023
B*39:39:01 0.0023
B*15:01 0.0023
B*44:02*** 0.0023
B*44:02:01:01 0.0023
B*42:02 0.0023
B*42:02:01:02 0.0023
Table 1. Allelic frequencies of HLA class I (HLA-A, -B and -C) in 218 Lacandon Native Americans. A.F.: Allele 
frequency. HLA-B alleles marked with *** are classified as HLA-Bw4 alleles132. HLA-C alleles marked with *** 
are classified as HLA-C2 alleles91.
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database57. We first tested the correlation between genetic diversity for each gene and geographic distance from 
Africa. Distance was calculated from East Africa to the location of each sample set analyzed. The general out-
looks for (a) pathogen richness; (b) viral richness; (c) HLA class I (represented by its most polymorphic gene, 
HLA-B) genetic diversity; and (d) HLA class II (represented by its most polymorphic gene, HLA-DRB1) genetic 
diversity are shown in Fig. 6. We ran linear regressions for the PIC values for all three HLA loci vs. the geo-
graphic distance from Africa (Supplementary Fig. 4). We found a similar tendency for the three genes analyzed: 
a general decrease in diversity when distance from Africa increases (HLA-A: r2 = 0.5444; HLA-B: r2 = 0.2787; 
HLA-DRB1: r2 = 0.3352; all these r2 values correspond to regressions ran after removing outliers). We then ran 
general linear models including both distance from Africa and either pathogen richness (Supplementary Table 3) 
HLA-DRB1 
protein HLA-DRB1 allele A.F.
HLA-DRB3/4/5 
protein
HLA-DRB3/4/5 
allele A.F.
HLA-DQA1 
protein HLA-DQA1 allele A.F.
HLA-DPA1 
protein HLA-DPA1 allele A.F.
DRB1*04:11 0.3624 DRB4*01:01 0.3493 DQA1*03:01 0.6950 DPA1*01:03 0.9014
DRB1*04:11:01 0.3555 DRB4*01:03 0.3472 DQA1*03:01:01 0.6950 DPA1*01:03:01:01 0.0373
DRB1*04:11:04 0.0046 DRB4*01:03:01:01 0.3403 DQA1*05:05 0.1055 DPA1*01:03:01:02/03 0.1196
DRB1*04:11:18 0.0023 DRB4*01:03:02e1 0.0069 DQA1*05:05:01:01 0.1055 DPA1*01:03:01:04 0.7376
DRB1*04:07 0.2385 DRB3*01:01 0.1027 DQA1*05:03 0.0872 DPA1*01:03:03 0.0046
DRB1*04:07:01 0.2293 DRB3*01:01:02:01 0.1004 DQA1*04:01 0.0711 DPA1*01:03:04 0.0023
DRB1*04:04 0.0711 DRB3*01:01:02:02 0.0023 DQA1*04:01:01 0.0688 DPA1*02:02 0.0665
DRB1*04:04:01 0.0688 DRB5*02:02 0.0633 DQA1*04:01:02:01 0.0023 DPA1*02:02:02 0.0487
DRB1*16:02 0.0642 DRB5*02:02e1 0.0633 DQA1*01:01 0.0138 DPA1*02:01 0.0252
DRB1*16:02:01 0.0642 DRB3*02:02 0.0373 DQA1*01:01:02 0.0023 DPA1*02:01:01 0.0206
DRB1*14:02 0.0573 DRB3*02:02:01:01 0.0327 DQA1*02:01 0.0069 DPA1*01:11 0.0023
DRB1*14:02:01 0.0590 DRB3*02:02:01:02 0.0046 DQA1*01:02 0.0069 DPA1*01:12 0.0023
DRB1*08:02 0.0596 DRB4*01:05 0.0092 DQA1*01:02:01:01 0.0023 DPA1*02:03 0.0023
DRB1*08:02:01 0.0550 DRB5*01:01 0.0046 DQA1*01:02:01:03 0.0023 HLA-DPB1 protein HLA-DPB1 allele A.F.
DRB1*08:02:03 0.0046 DRB3*03:01 0.0023 DQA1*01:02:01:04 0.0023
DRB1*14:06 0.0390 DQA1*03:03 0.0046 DPB1*04:02 0.7775
DRB1*14:06:01 0.0371 DQA1*03:03:01 0.0046 DPB1*04:02:01:01 0.0399
DRB1*11:04 0.0275 DQA1*05:01 0.0046 DPB1*04:02:01:02 0.7376
DRB1*11:04:01 0.0275 DQA1*05:01:02 0.0046 DPB1*05:01 0.0665
DRB1*04:03 0.0206 DQA1*01:03 0.0023 DPB1*05:01:01 0.0577
DRB1*04:03:01 0.0183 DQA1*01:03:01:02 0.0023 DPB1*04:01 0.0619
DRB1*04:03:02 0.0023 DQA1*01:05 0.0023 DPB1*04:01:01:01 0.0619
DRB1*08:01 0.0092 DQA1*01:05:01 0.0023 DPB1*02:01 0.0390
DRB1*01:02 0.0069 HLA-DQB1 protein HLA-DQB1 allele A.F. DPB1*02:01:02 0.0286
DRB1*13:03 0.0069 DPB1*03:01 0.0183
DRB1*13:03:01 0.0069 DQB1*03:02 0.6950 DPB1*03:01:01 0.0137
DRB1*01:01 0.0046 DQB1*03:02:01 0.6756 DPB1*14:01 0.0092
DRB1*15:01 0.0046 DQB1*03:02:02 0.0194 DPB1*14:01:01 0.0092
DRB1*04:05 0.0023 DQB1*03:01 0.1927 DPB1*11:01 0.0069
DRB1*04:10 0.0023 DQB1*03:01:01:01 0.1593 DPB1*11:01:01 0.0069
DRB1*04:10:01 0.0023 DQB1*03:01:01:03 0.0334 DPB1*17:01 0.0069
DRB1*04:17 0.0023 DQB1*04:02 0.0711 DPB1*17:01 0.0069
DRB1*04:51 0.0023 DQB1*04:02:01 0.0711 DPB1*10:01 0.0046
DRB1*04:91 0.0023 DQB1*05:01 0.0161 DPB1*10:01:01 0.0046
DRB1*04:154 0.0023 DQB1*05:01:01:01 0.0046 DPB1*105:01 0.0046
DRB1*07:01 0.0023 DQB1*05:01:01:02 0.0023 DPB1*126:01 0.0046
DRB1*07:01:01:01 0.0023 DQB1*02:02 0.0069 DPB1*01:01 0.0023
DRB1*10:01 0.0023 DQB1*02:02:01:01 0.0069 DPB1*01:01:01 0.0023
DRB1*11:18 0.0023 DQB1*03:04 0.0069 DPB1*51:01 0.0023
DRB1*11:42 0.0023 DQB1*03:04:01 0.0046
DRB1*12:01 0.0023 DQB1*03:04:02 0.0023
DRB1*12:01:01 0.0023 DQB1*06:03 0.0046
DRB1*13:01 0.0023 DQB1*03:03 0.0023
DRB1*13:01:01 0.0023 DQB1*06:02 0.0023
DRB1*13:02 0.0023 DQB1*06:04 0.0023
DRB1*14:41 0.0023
Table 2. Allelic frequencies of HLA class II genes (HLA-DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1 and -DPB1) 
in 218 Lacandon Native Americans. A.F.: Allele frequency.
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or viral richness (Supplementary Table 4) as predictor variables. No relationships were apparent between HLA-A 
or HLA-B diversity and either pathogen or viral richness. The 95% confidence interval for the gradient of the 
relationship between HLA-DRB1 diversity and both pathogen and viral richness suggests a negative relation-
ship (Supplementary Tables 3 and 4), but these relationships do not retain significance following a Bonferroni 
correction. Furthermore, only the negative relationship between viral richness and HLA-DRB1 diversity in the 
non-Native American populations retains a 95% confidence interval < 0 in the analysis excluding outliers.
Discussion
In this work, we used next generation sequencing to carry out high resolution typing of the HLA-A to HLA-DPB1 
loci in a group of Lacandon Maya settled in the Lacandon Rainforest in the lowlands of Chiapas State in the 
southeast of Mexico. We determined the distribution of HLA alleles and CEHs and their possible ancestral ori-
gin, and assessed genetic diversity within the classical HLA genes. We also put together this Lacandon Maya 
Block H.F. n (N = 218) Δ′ p t
B*40:02~C*03:04 0.2024 88 0.6876 <0.0001 22.5
B*35:01~C*07:02 0.1656 72 0.6320 <0.0001 14.4
B*39:05~C*07:02 0.1610 70 0.9566 <0.0001 19.3
B*35:12~C*04:01 0.1058 46 0.9505 <0.0001 15.4
B*40:08~C*03:04 0.0667 29 1.0000 <0.0001 11.4
B*35:01~C*04:01 0.0483 21 0.0656 0.2187 1.9
B*40:02~C*15:02 0.0414 18 0.9279 <0.0001 8.5
B*18:01~C*07:01 0.0276 12 1.0000 <0.0001 7.4
B*40:02~C*03:05 0.0184 8 1.0000 <0.0001 5.7
B*39:01~C*07:02 0.0138 6 1.0000 0.0015 4.9
B*39:06~C*07:02 0.0138 6 1.0000 0.00153 4.9
B*39:08~C*07:02 0.0138 6 1.0000 0.00153 4.9
B*35:43~C*01:02 0.0115 5 1.0000 <0.0001 4.5
B*44:03~C*16:01 0.0115 5 1.0000 <0.0001 4.5
B*52:01~C*03:03 0.0115 5 1.0000 <0.0001 4.5
B*14:02~C*08:02 0.0092 4 1.0000 <0.0001 4.0
B*07:02~C*07:02 0.0069 3 1.0000 0.02555 3.4
B*35:17~C*04:01 0.0069 3 1.0000 0.0002 3.5
B*49:01~C*07:01 0.0069 3 1.0000 <0.0001 3.5
B*35:08~C*04:01 0.0046 2 1.0000 0.0022 2.8
B*35:12~C*07:02 0.0046 2 −0.8918 <0.0001 −7.4
B*39:02~C*03:04 0.0046 2 1.0000 0.02502 2.8
B*39:05~C*04:01 0.0046 2 −0.8467 0.00023 −7.2
B*40:11~C*03:04 0.0046 2 1.0000 0.02502 2.8
B*51:01~C*15:04 0.0046 2 1.0000 <0.0001 2.8
B*53:01~C*04:01 0.0046 2 1.0000 0.0022 2.8
B*13:02~C*06:02 0.0023 1 1.0000 <0.0001 2.0
B*15:01~C*01:02 0.0023 1 1.0000 <0.0001 2.0
B*35:01~C*03:04 0.0023 1 −0.9635 <0.0001 −10.1
B*35:14~C*04:01 0.0023 1 1.0000 0.0305 2.0
B*39:39~C*01:02 0.0023 1 1.0000 <0.0001 2.0
B*40:02~C*04:01 0.0023 1 −0.9531 <0.0001 −9.2
B*42:02~C*17:01 0.0023 1 1.0000 <0.0001 2.0
B*44:02~C*05:01 0.0023 1 1.0000 <0.0001 2.0
B*51:01~C*08:01 0.0023 1 1.0000 <0.0001 2.0
B*51:01~C*15:02 0.0023 1 0.2168 0.0385 1.7
B*52:01~C*12:02 0.0023 1 1.0000 <0.0001 2.0
B*52:01~C*15:15 0.0023 1 1.0000 <0.0001 2.0
Native American blocks ABF: 0.8441
European blocks ABF: 0.0590
African blocks ABF: 0.0138
Asian blocks ABF: 0.0046
Not previously reported blocks ABF: 0.0782
Table 3. HLA-B~C blocks* in 218 Lacandon Native Americans. *Only haplotypes found more than once (H.F.: 
Haplotype frequency ≥ 0.0046) were included in the table. ABF: Aggregate block frequency.
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population with other populations, both Native American and non-Native American, to asses not only genetic 
relationships but also their general tendency when correlating the genetic diversity of these populations with the 
geographic distance from Africa and both pathogen and viral richness.
The PCA plot (Fig. 2) showed that the Lacandon population is genetically similar to other Native American 
populations, such as Mayos28, Teenek58, Seri25, Maya30, Wayu33, and Quechua34. When we performed a phyloge-
netic analysis of the relationship between the Lacandon and other North and South American Native populations, 
we found that the Lacandon belonged to the same clade as Native North Americans from Oaxaca (Mixe, Mixtec 
and Zapotecs)29 and the very divergent Yucpa from Venezuela35. However, these analyses were performed using 
allelic frequencies, not haplotypic data. When it comes to HLA, allelic diversity in Mesoamerican-descent groups 
tends to group together most of the Native North American populations. Haplotypic diversity can distinguish 
finer scale relationships among Native American populations, reflecting that although a limited allelic diversity 
came into the continent when the first human settlers arrived, recombination played an important role in adap-
tation to new environments and population differentiation. This is exemplified by the fact that four out of the top 
ten CEH in the Lacandon were not previously reported (accounting for 30.58% of the total CEHs), although all 
four haplotypes contained alleles for both class I and class II that are commonly present in other Native American 
populations.
As it has been shown before49, Lacandon Mayans and other Mayan groups have a genetic component very 
distinct from other populations, even from those in the same (or at least related) linguistic families, or neigh-
boring populations. This uniqueness can also be detected in the HLA genomic region. Distinctive alleles pres-
ent in the Lacandon population include A*24:14 (A.F. = 0.0502; also found in the Mayan population from 
Guatemala with an A.F. = 0.004030, Buryat from Mongolia with an A.F. = 0.004059, and Saudi Arabia with and 
A.F. = 0.003260) and B*40:08 [A.F. = 0.0611; also found in Texas Hispanic from USA with an A.F. = 0.0170 (data 
collected by Cathi Murphey, available in61)], Polynesian from American Samoa with an A.F. = 0.010062 and 
HLA~DRB1~DRB3/4/5~DQB1~DQA1~DPA1~DPB1 haplotype H.F.
n 
(N = 218) Δ′ p t
DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.2047 89 0.6566 <0.0001 4.6
DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.1449 63 0.6379 0.0012 3.8
DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.1196 52 0.1168 0.5642 0.5
DRB1*16:02~DRB5*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*04:02 0.0575 25 0.5539 0.0890 2.0
DRB1*08:02~NULL~DQB1*04:02~DQA1*04:01~DPA1*01:03~DPB1*04:02 0.0552 24 0.5374 0.1056 1.9
DRB1*04:07~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0529 23 −0.0541 0.5728 −0.5
DRB1*14:02~DRB3*01:01~DQB1*03:01~DQA1*05:03~DPA1*01:03~DPB1*04:02 0.0414 18 −0.0129 0.9079 −0.1
DRB1*04:04~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0276 12 −0.0129 0.9254 −0.1
DRB1*14:06~DRB3*01:01~DQB1*03:01~DQA1*05:03~DPA1*01:03~DPB1*04:01 0.0253 11 0.8361 <0.0001 6.7
DRB1*04:04~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0230 10 0.6024 <0.0001 6.3
DRB1*11:04~DRB3*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*04:02 0.0184 8 −0.1901 0.2162 −1.0
DRB1*04:04~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0138 6 −0.5065 0.0002 −2.5
DRB1*04:03~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0115 5 1.0000 0.2062 2.1
DRB1*04:07~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0092 4 0.0903 0.0837 2.4
DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*02:01 0.0092 4 0.1065 0.2753 1.7
DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*02:01 0.0092 4 0.0298 0.8090 0.4
DRB1*04:03~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 1.0000 0.3286 1.6
DRB1*04:04~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0069 3 0.1386 0.0214 2.6
DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:01 0.0069 3 −0.2565 0.5655 −1.1
DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0069 3 −0.4552 0.2154 −2.4
DRB1*08:01~NULL~DQB1*04:02~DQA1*04:01~DPA1*01:03~DPB1*04:01 0.0069 3 0.7337 <0.0001 3.4
DRB1*01:01~NULL~DQB1*05:01~DQA1*01:01~DPA1*01:03~DPB1*04:01 0.0046 2 1.0000 <0.0001 2.8
DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*03:01 0.0046 2 0.1590 0.3141 1.5
DRB1*04:07~DRB4*01:05~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 1.0000 0.4255 1.3
DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0046 2 −0.4662 0.3152 −2.1
DRB1*11:04~DRB3*02:02~DQB1*03:01~DQA1*05:05~DPA1*02:02~DPB1*05:01 0.0046 2 0.1029 0.1249 1.9
DRB1*13:03~DRB3*02:02~DQB1*02:02~DQA1*02:01~DPA1*02:02~DPB1*11:01 0.0046 2 1.0000 <0.0001 2.8
DRB1*16:02~DRB5*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*02:01 0.0046 2 0.0602 0.3216 1.4
Native American MPA blocks ABF: 0.6854
European MPA blocks ABF: 0.1196
African MPA blocks ABF: 0.0138
Asian MPA blocks ABF: 0.0184
Not previously reported blocks ABF: 0.1628
Table 4. HLA class II (HLA-DRB1~DRB3|4|5~DQB1~DQA1~DPA1~DPB1) haplotypes* in 218 Lacandon 
Native Americans. *Only haplotypes found more than once (H.F.: Haplotype frequency ≥ 0.0046) were 
included. ABF: Aggregate block frequency.
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northern India with an A.F. = 0.010063. Furthermore, we observed a high frequency of haplotypes containing 
the allele HLA-DRB1*04:11 in Lacandons, an allele that was found with a frequency of 0.3690, which is the 
highest frequency when compared to other neighboring indigenous groups29,30. Other authors37 have reported 
class II HLA alleles in the Lacandon (N = 162), and found an even higher frequency of HLA-DRB1*04:11 (Our 
study 0.3690 vs. ref. 37 0.5740, p = 0.0002). Only two out of nine HLA class II blocks present in previous reports37 
and in our study were found to be at different frequencies: HLA-DRB1*04:11~DQB1*03:02 (0.3688 vs. 0.5670, 
p = 0.0001) and HLA-DRB1*04:07~DQB1*03:02 (0.2398 vs. 0.0960, p = 0.0003). Several studies have suggested 
that HLA-DRB1*04:11 allele is of Native American MPA and is frequent in several Native North and South 
American populations including Tarahumaras from Mexico, Wayúu from Venezuela, Mataco-Wichi, Toba 
Pilaga and Eastern Toba from Argentina, and Cayapa from Ecuador26,33,45,61,64,65. Recent reports have associated 
the HLA-DRB1*04:11 allele with an increased susceptibility to pulmonary tuberculosis in Amazon Brazilian 
Conserved extended haplotype (CEH) H.F. n (N = 218) Δ′ p t
B*40:02~C*03:04~DRB1*04:11~DQB1*03:02 0.1702 74 0.6663 <0.0001 15.4
B*35:12~C*04:01~DRB1*04:11~DQB1*03:02 0.0759 33 0.5328 <0.0001 7.9
B*39:05~C*07:02~DRB1*04:07~DQB1*03:02 0.0759 33 0.2992 <0.0001 7.4
B*35:01~C*07:02~DRB1*04:11~DQB1*03:02 0.0575 25 −0.0679 0.6306 −0.7
B*35:01~C*07:02~DRB1*16:02~DQB1*03:01 0.0483 21 0.6710 <0.0001 8.9
B*40:08~C*03:04~DRB1*04:07~DQB1*03:02 0.0460 20 0.5985 <0.0001 7.8
B*39:05~C*07:02~DRB1*04:11~DQB1*03:02 0.0414 18 −0.3102 0.0306 −3.1
B*35:01~C*07:02~DRB1*04:07~DQB1*03:02 0.0368 16 −0.0478 0.8076 −0.4
B*40:02~C*03:04~DRB1*14:02~DQB1*03:01 0.0345 15 0.4677 <0.0001 6.2
B*35:01~C*04:01~DRB1*04:04~DQB1*03:02 0.0322 14 0.6416 <0.0001 7.5
B*40:02~C*15:02~DRB1*14:06~DQB1*03:01 0.0322 14 0.8699 <0.0001 7.7
B*18:01~C*07:01~DRB1*11:04~DQB1*03:01 0.0253 11 0.8417 <0.0001 6.8
B*39:05~C*07:02~DRB1*16:02~DQB1*03:01 0.0161 7 0.0999 0.1982 2.0
B*35:12~C*04:01~DRB1*04:07~DQB1*03:02 0.0138 6 −0.4378 0.0859 −3.1
B*39:05~C*07:02~DRB1*08:02~DQB1*04:02 0.0115 5 0.0332 0.6805 0.7
B*40:02~C*03:05~DRB1*04:07~DQB1*03:02 0.0115 5 0.5148 0.0067 3.5
B*40:08~C*03:04~DRB1*04:03~DQB1*03:02 0.0115 5 0.5255 <0.0001 4.3
B*35:12~C*04:01~DRB1*08:02~DQB1*04:02 0.0092 4 0.0507 0.4216 1.3
B*35:43~C*01:02~DRB1*04:07~DQB1*03:02 0.0092 4 0.7412 0.0021 3.6
B*39:08~C*07:02~DRB1*04:07~DQB1*03:02 0.0092 4 0.5687 0.0097 3.3
B*52:01~C*03:03~DRB1*04:04~DQB1*03:02 0.0092 4 0.7850 <0.0001 4.0
B*35:01~C*04:01~DRB1*08:02~DQB1*04:02 0.0069 3 0.0892 0.0947 2.2
B*35:01~C*07:02~DRB1*04:03~DQB1*03:02 0.0069 3 0.2049 0.1574 2.0
B*39:01~C*07:02~DRB1*04:11~DQB1*03:02 0.0069 3 0.2158 0.4805 1.1
B*39:05~C*07:02~DRB1*14:02~DQB1*03:01 0.0069 3 −0.2660 0.5464 −1.2
B*39:06~C*07:02~DRB1*04:04~DQB1*03:02 0.0069 3 0.4624 <0.0001 3.2
B*14:02~C*08:02~DRB1*01:01~DQB1*05:01 0.0046 2 1.0000 <0.0001 2.8
B*14:02~C*08:02~DRB1*01:02~DQB1*05:01 0.0046 2 0.6637 <0.0001 2.8
B*35:01~C*04:01~DRB1*04:07~DQB1*03:02 0.0046 2 −0.5806 0.1399 −2.9
B*35:01~C*04:01~DRB1*04:11~DQB1*03:02 0.0046 2 −0.7372 0.0091 −4.1
B*35:01~C*07:02~DRB1*04:04~DQB1*03:02 0.0046 2 −0.6132 0.1144 −3.4
B*35:01~C*07:02~DRB1*08:02~DQB1*04:02 0.0046 2 −0.5415 0.2029 −2.7
B*35:12~C*04:01~DRB1*14:02~DQB1*03:01 0.0046 2 −0.2504 −0.6566 −0.9
B*39:01~C*07:02~DRB1*04:07~DQB1*03:02 0.0046 2 0.1375 0.5317 1.0
B*40:02~C*15:02~DRB1*08:02~DQB1*04:02 0.0046 2 0.0554 0.3378 1.4
B*40:08~C*03:04~DRB1*04:11~DQB1*03:02 0.0046 2 −0.8097 0.0007 −5.3
B*40:11~C*03:04~DRB1*08:02~DQB1*04:02 0.0046 2 1.0000 <0.0001 2.8
B*51:01~C*15:04~DRB1*04:04~DQB1*03:02 0.0046 2 1.0000 <0.0001 2.8
B*53:01~C*04:01~DRB1*13:03~DQB1*02:02 0.0046 2 1.0000 <0.0001 2.8
Native American MPA CEH frequency: 0.3188
European MPA CEH frequency: 0.0917
African MPA CEH frequency: 0.0023
Asian MPA CEH frequency: 0.0023
Not previously reported CEH frequency: 0.6055
Table 5. HLA Conserved Extended Haplotypes* (CEH) in 218 Lacandon Native Americans. *Only haplotypes 
found more than once (H.F.: Haplotype frequency ≥ 0.0046) were included.
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HLA~A~B~C~DRB1~DQB1 haplotype H.F.
n 
(N = 218) Δ′ p t
A*31:01~B*40:02~C*03:04~DRB1*04:11~DQB1*03:02 0.1311 57 0.9216 0.0000 14.8
A*02:06~B*35:01~C*07:02~DRB1*04:11~DQB1*03:02 0.0483 21 0.4003 0.0013 4.7
A*24:02~B*35:12~C*04:01~DRB1*04:11~DQB1*03:02 0.0483 21 0.6079 0.0000 6.3
A*68:03~B*35:01~C*07:02~DRB1*16:02~DQB1*03:01 0.0483 21 0.7020 0.0000 9.1
A*68:01~B*40:08~C*03:04~DRB1*04:07~DQB1*03:02 0.0460 20 0.6303 0.0000 7.7
A*68:01~B*39:05~C*07:02~DRB1*04:11~DQB1*03:02 0.0414 18 0.5608 0.0001 5.5
A*68:03~B*39:05~C*07:02~DRB1*04:07~DQB1*03:02 0.0391 17 0.6226 0.0000 7.0
A*24:02~B*40:02~C*15:02~DRB1*14:06~DQB1*03:01 0.0322 14 1.0000 0.0000 7.5
A*02:01~B*18:01~C*07:01~DRB1*11:04~DQB1*03:01 0.0253 11 0.8417 0.0000 6.6
A*02:01~B*35:12~C*04:01~DRB1*04:11~DQB1*03:02 0.0230 10 0.7386 0.0006 4.9
A*24:14~B*35:01~C*04:01~DRB1*04:04~DQB1*03:02 0.0230 10 1.0000 0.0000 6.2
A*02:06~B*40:02~C*03:04~DRB1*04:11~DQB1*03:02 0.0207 9 0.5174 0.0121 3.6
A*24:14~B*40:02~C*03:04~DRB1*14:02~DQB1*03:01 0.0207 9 0.8072 0.0000 5.8
A*02:06~B*35:01~C*07:02~DRB1*04:07~DQB1*03:02 0.0161 7 −0.0933 0.7592 −0.5
A*24:02~B*39:05~C*07:02~DRB1*04:07~DQB1*03:02 0.0161 7 0.4029 0.0066 3.6
A*68:03~B*35:01~C*07:02~DRB1*04:07~DQB1*03:02 0.0161 7 −0.0933 0.7592 −0.5
A*68:01~B*40:08~C*03:04~DRB1*04:03~DQB1*03:02 0.0115 5 0.5266 0.0000 4.2
A*24:02~B*35:12~C*04:01~DRB1*04:07~DQB1*03:02 0.0092 4 −0.3709 0.2723 −2.0
A*68:05~B*39:05~C*07:02~DRB1*04:07~DQB1*03:02 0.0092 4 0.5687 0.0097 3.2
A*02:01~B*35:43~C*01:02~DRB1*04:07~DQB1*03:02 0.0069 3 1.0000 0.0013 3.3
A*02:06~B*40:02~C*03:04~DRB1*14:02~DQB1*03:01 0.0069 3 0.1845 0.0060 2.7
A*02:06~B*52:01~C*03:03~DRB1*04:04~DQB1*03:02 0.0069 3 1.0000 0.0000 3.4
A*24:02~B*39:06~C*07:02~DRB1*04:04~DQB1*03:02 0.0069 3 0.4624 0.0000 3.1
A*68:01~B*39:01~C*07:02~DRB1*04:11~DQB1*03:02 0.0069 3 0.6079 0.1053 2.3
A*68:01~B*39:05~C*07:02~DRB1*16:02~DQB1*03:01 0.0069 3 0.0605 0.2314 1.7
A*68:03~B*35:01~C*07:02~DRB1*04:11~DQB1*03:02 0.0069 3 −0.7566 0.0005 −5.2
A*02:01~B*35:12~C*04:01~DRB1*08:02~DQB1*04:02 0.0046 2 0.1145 0.1084 1.9
A*02:06~B*35:01~C*04:01~DRB1*04:04~DQB1*03:02 0.0046 2 1.0000 0.0000 2.7
A*02:06~B*35:01~C*07:02~DRB1*04:03~DQB1*03:02 0.0046 2 0.1599 0.0872 1.9
A*02:06~B*35:01~C*07:02~DRB1*04:04~DQB1*03:02 0.0046 2 −0.1581 0.7929 −0.5
A*02:06~B*39:08~C*07:02~DRB1*04:07~DQB1*03:02 0.0046 2 0.5687 0.0682 2.2
A*02:06~B*40:02~C*15:02~DRB1*08:02~DQB1*04:02 0.0046 2 1.0000 0.0000 2.7
A*24:02~B*35:01~C*04:01~DRB1*04:04~DQB1*03:02 0.0046 2 0.3549 0.0036 2.4
A*24:02~B*35:01~C*04:01~DRB1*04:11~DQB1*03:02 0.0046 2 0.0589 0.8606 0.3
A*24:02~B*39:05~C*07:02~DRB1*08:02~DQB1*04:02 0.0046 2 0.1008 0.1406 1.8
A*24:02~B*40:02~C*03:04~DRB1*04:11~DQB1*03:02 0.0046 2 0.2158 0.5654 0.9
A*24:02~B*40:02~C*03:04~DRB1*14:02~DQB1*03:01 0.0046 2 0.4699 0.0001 2.6
A*24:02~B*40:02~C*03:05~DRB1*04:07~DQB1*03:02 0.0046 2 1.0000 0.0089 2.7
A*24:14~B*40:02~C*03:04~DRB1*04:11~DQB1*03:02 0.0046 2 −0.4984 0.2071 −2.0
A*33:01~B*14:02~C*08:02~DRB1*01:02~DQB1*05:01 0.0046 2 1.0000 0.0000 2.7
A*68:01~B*35:01~C*04:01~DRB1*04:07~DQB1*03:02 0.0046 2 1.0000 0.0089 2.7
A*68:01~B*39:05~C*07:02~DRB1*04:07~DQB1*03:02 0.0046 2 −0.6477 0.0710 −3.5
A*68:02~B*53:01~C*04:01~DRB1*13:03~DQB1*02:02 0.0046 2 1.0000 0.0000 2.7
A*68:03~B*39:01~C*07:02~DRB1*04:07~DQB1*03:02 0.0046 2 1.0000 0.0089 2.7
A*68:03~B*39:05~C*07:02~DRB1*08:02~DQB1*04:02 0.0046 2 0.0259 0.6024 0.8
A*68:03~B*39:05~C*07:02~DRB1*16:02~DQB1*03:01 0.0046 2 0.0214 0.6792 0.7
Native American MPA CEH + HLA-A frequency: 0.1092
European MPA CEH + HLA-A frequency: 0.0480
African MPA CEH + HLA-A frequency: 0.0066
Asian MPA CEH + HLA-A frequency: 0.0349
Not previously reported CEH + HLA-A frequency: 0.7663
Table 6. The extension of HLA Conserved Extended Haplotypes* (CEH) to HLA−A in 218 Lacandon Native 
Americans. * Only haplotypes found more than once (H.F.: Haplotype frequency ≥ 0.0046) were included. 
MPA: Most probable ancestry. CEH: conserved extended haplotype.
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HLA~A~B~C~DRB1~DRB3/4/5~DQB1~DQA1~DPA1~DPB1 haplotype H.F. n (N = 218) Δ′ p t
A*31:01~B*40:02~C*03:04~DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0667 29 0.3587 <0.0001 8.3
A*31:01~B*40:02~C*03:04~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0529 23 0.3582 <0.0001 8.3
A*68:03~B*35:01~C*07:02~DRB1*16:02~DRB5*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*04:02 0.0414 18 0.6975 <0.0001 8.7
A*24:02~B*35:12~C*04:01~DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0368 16 0.4681 0.0000 6.6
A*68:01~B*39:05~C*07:02~DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0345 15 0.5035 <0.0001 6.5
A*02:06~B*35:01~C*07:02~DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0299 13 0.2334 0.0040 4.2
A*68:03~B*39:05~C*07:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0299 13 0.4686 0.0000 6.4
A*24:02~B*40:02~C*15:02~DRB1*14:06~DRB3*01:01~DQB1*03:01~DQA1*05:03~DPA1*01:03~DPB1*04:01 0.0253 11 1.0000 <0.0001 6.8
A*68:01~B*40:08~C*03:04~DRB1*04:07~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0230 10 0.3980 <0.0001 6.0
A*02:01~B*18:01~C*07:01~DRB1*11:04~DRB3*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*04:02 0.0161 7 0.8713 <0.0001 5.4
A*02:01~B*35:12~C*04:01~DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0161 7 0.4828 0.0006 4.3
A*02:06~B*35:01~C*07:02~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0161 7 0.1042 0.0777 2.6
A*68:01~B*40:08~C*03:04~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0138 6 0.0890 0.2238 1.9
A*24:14~B*35:01~C*04:01~DRB1*04:04~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0115 5 0.4888 <0.0001 4.5
A*02:06~B*35:01~C*07:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0092 4 −0.1447 0.7261 −0.7
A*24:14~B*40:02~C*03:04~DRB1*14:02~DRB3*01:01~DQB1*03:01~DQA1*05:03~DPA1*01:03~DPB1*04:02 0.0092 4 0.3376 <0.0001 3.8
A*68:03~B*35:01~C*07:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0092 4 −0.1447 0.7261 −0.7
A*02:01~B*35:43~C*01:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 1.0000 <0.0001 3.5
A*02:06~B*40:02~C*03:04~DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*02:01 0.0069 3 0.7427 <0.0001 3.5
A*02:06~B*40:02~C*03:04~DRB1*14:02~DRB3*01:01~DQB1*03:01~DQA1*05:03~DPA1*01:03~DPB1*04:02 0.0069 3 0.1993 0.0003 3.1
A*02:06~B*52:01~C*03:03~DRB1*04:04~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 1.0000 <0.0001 3.5
A*24:02~B*35:12~C*04:01~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 −0.2211 0.6297 −0.9
A*24:02~B*39:05~C*07:02~DRB1*04:07~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 0.1901 0.0025 2.9
A*24:02~B*39:06~C*07:02~DRB1*04:04~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 0.4865 <0.0001 3.4
A*68:01~B*39:01~C*07:02~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 0.7180 0.0001 3.3
A*68:01~B*39:05~C*07:02~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0069 3 0.0073 0.9166 0.2
A*68:01~B*39:05~C*07:02~DRB1*16:02~DRB5*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*04:02 0.0069 3 0.0692 0.1387 2.0
A*68:03~B*35:01~C*07:02~DRB1*04:07~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0069 3 0.7300 <0.0001 3.4
A*02:01~B*18:01~C*07:01~DRB1*11:04~DRB3*02:02~DQB1*03:01~DQA1*05:05~DPA1*02:02~DPB1*05:01 0.0046 2 1.0000 <0.0001 2.8
A*02:01~B*35:12~C*04:01~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.0599 0.5566 0.9
A*02:01~B*35:12~C*04:01~DRB1*08:02~NULL~DQB1*04:02~DQA1*04:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.1206 0.0719 2.1
A*02:06~B*35:01~C*07:02~DRB1*04:07~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.0137 0.8113 0.4
A*02:06~B*39:08~C*07:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.6135 0.0076 2.6
A*02:06~B*40:02~C*03:04~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*02:01 0.0046 2 0.4854 <0.0001 2.8
A*02:06~B*40:02~C*03:04~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.0455 0.6421 0.8
A*24:02~B*35:12~C*04:01~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 −0.3709 0.4685 −1.5
A*24:02~B*39:05~C*07:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.0189 0.8626 0.3
A*24:02~B*39:05~C*07:02~DRB1*08:02~NULL~DQB1*04:02~DQA1*04:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.1071 0.0959 2.0
A*24:02~B*40:02~C*03:04~DRB1*14:02~DRB3*01:01~DQB1*03:01~DQA1*05:03~DPA1*01:03~DPB1*04:02 0.0046 2 0.4795 <0.0001 2.7
A*24:14~B*35:01~C*04:01~DRB1*04:04~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.3185 <0.0001 2.7
A*24:14~B*35:01~C*04:01~DRB1*04:04~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0046 2 0.6592 <0.0001 2.8
A*24:14~B*40:02~C*03:04~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.0770 0.4699 1.1
A*31:01~B*40:02~C*03:04~DRB1*04:11~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*02:02~DPB1*05:01 0.0046 2 1.0000 0.0003 2.8
A*68:01~B*40:08~C*03:04~DRB1*04:03~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.6450 <0.0001 2.7
A*68:01~B*40:08~C*03:04~DRB1*04:03~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.3609 0.0015 2.6
A*68:01~B*40:08~C*03:04~DRB1*04:07~DRB4*01:05~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 1.0000 <0.0001 2.8
A*68:02~B*53:01~C*04:01~DRB1*13:03~DRB3*02:02~DQB1*02:02~DQA1*02:01~DPA1*02:02~DPB1*11:01 0.0046 2 1.0000 <0.0001 2.8
A*68:03~B*35:01~C*07:02~DRB1*04:11~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 −0.6973 0.0380 −4.3
A*68:03~B*35:01~C*07:02~DRB1*16:02~DRB5*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*02:01 0.0046 2 1.0000 <0.0001 2.8
A*68:03~B*39:01~C*07:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 1.0000 0.0004 2.8
A*68:03~B*39:05~C*07:02~DRB1*04:07~DRB4*01:03~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.0365 0.4454 1.2
A*68:03~B*39:05~C*07:02~DRB1*08:02~NULL~DQB1*04:02~DQA1*04:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.0326 0.4848 1.1
A*68:03~B*39:05~C*07:02~DRB1*16:02~DRB5*02:02~DQB1*03:01~DQA1*05:05~DPA1*01:03~DPB1*04:02 0.0046 2 0.0304 0.5242 1.0
A*68:05~B*39:05~C*07:02~DRB1*04:07~DRB4*01:01~DQB1*03:02~DQA1*03:01~DPA1*01:03~DPB1*04:02 0.0046 2 0.2270 0.1611 1.8
Table 7. HLA-A~B~C~DRB1~DRB3/4/5~DQB1~DQA1~DPA1~DPB1 haplotypes* in 218 Lacandon Native 
Americans. * Only haplotypes found more than once (H.F.: Haplotype frequency ≥ 0.0046) were included.
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population66. One SNP position in LD with non-DRB3, non-DRB5 haplotypes (i.e. the ones not linked with 
HLA-DRB1*04 allelic group, for instance) has been reported to be associated with a positive tuberculosis test in 
a recent study using genome-wide data paired with fine-mapping of the HLA region67. Although the significance 
is marginal, this finding further supports the involvement of the region in the susceptibility of tuberculosis. Also, 
the HLA-DRB1*04 allelic group alleles, highly prevalent in Lacandon Mayans, have been suggested to have a 
protective effect against hepatitis B virus infection68.
A high frequency of “rare alleles or haplotypes” may be present due to genetic isolation and small population 
number, both of which increase the effects of genetic drift. Class I (ABF: 0.4847), class II (ABF: 0.1659) and CEH 
(ABF: 0.5786) haplotypes previously unreported in Native American population account for an important part 
of haplotypic diversity in the Lacandon population, and they point to a distinctive Native American root that 
was overlooked until recent times49. For instance, haplotype HLA-A*31:01~B*40:02~C*03:04 (H.F: = 0.1310) 
was previously reported only in East Asian populations such as Japanese69,70, Chinese71 and Malaysia Peninsular 
Chinese (data collected by Sulaiman Salsabil, available in61), but it was also reported in mixed-ancestry popula-
tions such as Mexico City72 and “Hispanics” from USA73. Its frequency in Lacandon Maya is the highest frequency 
ever reported for this haplotype which would be indicative of a Native American MPA haplotype that can be 
traced back to its original East Asian ancestry thousands of years ago. HLA-B*35~C*07 associations, although 
uncommon, have been previously reported in Native North American populations such as Mixtec and Mixe29 
but also in some Asian populations such as Rakhine from Myanmar (data collected by Thu ZinZin, available 
in61). Again, Lacandon Maya exhibit the highest frequency (H.F.: 0.1659) of this haplotype ever reported for any 
population. The reasons why these associations have never been previously found in Native American human 
groups include biased sampling procedures, but may also reflect genetic drift or pathogen selection having led to 
the extinction of specific haplotypes in other Native American groups, or the elevation of specific haplotypes in 
the Lacandon.
It is important to note that a European haplotype is present as part of the top ten most frequent haplotypes 
in our sample: A*02:01~B*18:01~C*07:01~DRB1*11:04~DQB1*03:01, with 2.40% (Table 6). That haplotype 
has been reported in frequencies ranging from 0.91% to 7.32% in populations from eastern and Mediterranean 
regions from Europe, such as Albania, Macedonia, Greece, Bosnia and Herzegovina, Romania and Italy71,74–78. 
The only African haplotype present at least twice in our sample was A*68:02~B*53:01~C*04:01~DRB1*13:03
~DQB1*02:02 (HF = 0.44%; Table 6). This class I and class II haplotype can only be found in mixed ancestry 
populations such as Mexicans from Mexico City72 and African Americans73, but the class I block is present in 
populations from sub Saharan Africa such as the Bandiagara from Mali79, the Nandi and Luo from Kenya79,80 and 
the multicultural Worcester region in South Africa81. These two examples of non-Native American haplotypes 
give account of admixture events consistent with the ancestries brought into the Americas by conquerors during 
the conquest wars period and the colonial times82,83, even in what is considered to be one of the most isolated 
Native American human groups52,53.
HLA molecules have an important biological role as Killer cell Immunoglobulin-like Receptor (KIR) lig-
ands. KIR2DL1, KIR2DL2/3 and KIR3DL1 bind HLA-C2, -C1 and -Bw4 ligands respectively, resulting in inhi-
bition of natural killer (NK) cell-mediated cytolysis. C2, C1 and Bw4 are all found on HLA class I molecules: C1 
and C2 are exclusive to HLA-C, while Bw4 can be found on some HLA-B and some HLA-A molecules. Several 
physiological functions of Natural Killer (NK) cells in human immunity and reproduction depend upon diverse 
interactions between KIRs and their HLA class I ligands84–87. In most populations, HLA-Bw4 alleles (i.e. those 
carrying asparagine, aspartic acid or serine in amino acid residue 77 and isoleucine or threonine in amino acid 
residue 80) are present in nearly 50% of the haplotypes, which means that around 75% of the individuals of any 
given population should express a ligand for the KIR3DL1 receptor88,89. Only 0.0503 of the HLA-B alleles pres-
ent in Lacandon Maya are HLA-Bw4 alleles, and most of them (B*44:02, B*44:03, B*49:01, and B*13:02) are of 
European MPA. Nonetheless, Lacandon Maya have a relatively high frequency (A.F.: 0.0568) of the Bw4+ HLA-A 
allotype A*24:14, which is known to inhibit and to educate NK cells through interaction with KIR3DL189,90. In 
our Lacandon sample, therefore, approximately 10.7% of haplotypes carry a Bw4+ ligand. HLA-C2 alleles are also 
inhibitory KIR ligands91; HLA-C2 frequencies in humans range from <10% in certain East Asian populations to 
Gene O. H. E. H. p value PIC PD
HLA-A 0.8739 0.8623 <0.0001 0.8444 0.9565
HLA-B 0.8018 0.8419 0.0001 0.8227 0.9417
HLA-C 0.6622 0.7410 <0.0001 0.6993 0.8846
HLA-DRB1 0.7149 0.7813 <0.0001 0.7555 0.9255
HLA-DRB3/4/5 0.4781 0.4938 0.0479 0.4692 0.7129
HLA-DQA1 0.4670 0.4773 0.0003 0.4521 0.6894
HLA-DQB1 0.4493 0.4698 0.0001 0.4257 0.6559
HLA-DPA1 0.1659 0.1665 0.0967 0.1581 0.2943
HLA-DPB1 0.3750 0.3672 0.1866 0.3547 0.5881
Table 8. Calculated parameters of genetic diversity at the allele level for HLA system in a sample of Lacandon 
individuals. O.H.: Observed heterozygosity. E.H.: Expected Heterozygosity. PIC: Polymorphism Information 
Contents. PD: Power of Discrimination. p values < 0.05 are considered statistically significant and thus reflect 
differences between O.H. and E.H.
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~60% in Oceania native human groups and some African populations. In our sample, the C2 ligand is present on 
0.2294 of the HLA-C alleles (Table 1). This level of HLA-C2 is consistent with other Native American populations 
in which HLA-C2 alleles are present in AF < 0.3 such as Barí (0.075) and Yucpa (0.214) from Venezuela’s tropical 
humid forests35,36, both of which share the same type of ecosystem with Lacandon Maya.
As expected, when PIC values observed in Lacandons (Table 8) are compared against those found in a mixed 
ancestry population72, diversity is lower in the Lacandon sample than in Mexico City. Nevertheless, Lacandon 
PIC values are higher than other Native American groups for the HLA-A locus (Lacandons: 0.8444; Guarani from 
Paraguay: 0.7810; Toba from Argentina: 0.7715; Terena from Brasil: 0.7540; Mixtec: 0.7525, Zapotec: 0.7400, and 
Mixe: 0.6800 from Oaxaca, Mexico) and HLA-B (Lacandons: 0.8227; Gila River Indian Community of Arizona: 
0.8167; Tarahumara from Mexico: 0.8093; Toba from Argentina: 0.7895; Mixtec: 0.7592, Zapotec: 0.7742, and 
Mixe: 0.3750 from Oaxaca, Mexico). Lacandon Maya HLA-A diversity as measured by PIC is the highest among 
Native American groups, and Lacandon HLA-B diversity is the third highest, just below Pilaga from Argentina 
and Sioux from USA. Conversely, HLA-DRB1 shows relatively low diversity in Lacandon, below that found 
in Native South American groups (Lacandons: 0.7555; Toba: 0.8580, Pilaga: 0.8328, and Eastern Toba: 0.8326 
from Argentina; Mapuche from Chile: 0.8333; Uro from Peru: 0.7879) and some Native North American groups 
(Zapotec from Oaxaca, Mexico: 0.8512; Sioux from USA: 0.8439).
In what could be called the “class I/class II diversity paradox”, the Lacandon population exhibits a relatively 
low diversity in HLA-DRB1 (globally one of the most variable regions in the human genome) compared to HLA-A 
and HLA-B. It is possible that the lower diversity of MHC class II genes in Native American populations (and, 
Figure 2. Principal Component Analysis for 163 populations (including the Lacandon group studied in this 
work). European populations are represented by green dots; African human groups correspond to yellow dots; 
red dots were assigned to Asian populations; Native American populations are represented by purple dots; 
Populations from Oceania are indicated with pink dots. Our Lacandon sample is represented by a purple star. 
For a view of the complete PCA, please refer to Supplementary Fig. 1. Argentina Gran Chaco Eastern Toba 
(n = 135) ArE; Argentina Gran Chaco Mataco Wichi (n = 49) ArM; Argentina Gran Chaco Western Toba Pilaga 
(n = 19) ArP; Argentina Rosario Toba (n = 86) ArT; Bolivia Aymara (n = 102) BoA; Bolivia Quechua (n = 80) 
BoQ; Brazil Ivaí Kaingang (n = 127) BrI; Brazil Río das cobras Guaraní (n = 98) BrG; Brazil Río das cobras 
Kaingang (n = 113) BrR; Brazil Terena (n = 60) BrT; Guatemala Maya (n = 132) GtM; Mexico Tarahumara 
(n = 44) MTa; Mexico Teenek (n = 55) MTe; Mexico Mayos (n = 60) MMa; Mexico Mazatecan (n = 89) MMz; 
Mexico Mixe (n = 55) MMx; Mexico Mixtec (n = 103) MMi; Mexico Zapotec (n = 90) MZa; Mexico Nahuas 
(n = 85) MNa; Mexico Seri (n = 34) MSe; Paraguay Guarani (n = 40) Py; Peru Lama (n = 83) PeL; Peru Titikaka 
Lake Uro (n = 105) PeU; USA Gila River (n = 492) USG; USA Sioux (n = 302) USS; USA Yupik (n = 252) 
USY; Venezuela Yucpa (n = 73) VeY. The complete list of abbreviations is included in Supplementary Table 1. 
Component 1 bears 35.23% of the total variance, while component 2 is explained by 16.62% of the variance. For 
the zoom-in of this PCA, please see Supplementary Fig. 1.
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by extension, in mixed populations with high proportions of Native American ancestry) might result from the 
frequency increase of some alleles that provide efficient immune protection against highly prevalent extracellular 
pathogens in specific populations6,7,15,19,72.
Previous studies have demonstrated a positive correlation between HLA class I allele diversity and pathogen 
richness and a negative correlation between HLA class II diversity and pathogen richness, raising the possibility 
that HLA class I and class II genes undergo different types of evolutionary trajectory in response to pathogen 
selection5,6. However, Sanchez Mazas et al.6 found that the significance of both their observed positive correlation 
between HLA class I allele diversity and pathogen richness and the negative correlation between HLA class II 
diversity and pathogen richness disappeared when Native American and Taiwanese populations were removed 
from the dataset. Native American populations have low HLA class II diversity in a high pathogen environ-
ment (this in turn seems to have helped to generate the previously observed negative correlation between class 
II diversity and pathogen richness). Is it possible that low HLA class II diversity can be a form of adaptation to 
a high pathogen environment? The class II HLA evolutionary mechanisms proposed by Sanchez-Mazas et al.6 
apply particularly to HLA-DQA1 and HLA-DQB1, whereas as noted previously the Lacandon also exhibit rela-
tively low diversity in HLA-DRB1. Certain HLA alleles appear to be promiscuous and are capable of binding an 
exceptionally large set of epitope peptide segments15. Since the HLA class II alleles commonly found in Native 
Americans (except for HLA-DRB1*16:02), and specifically those reported here for Lacandon Mayans, do not fall 
within the category of “promiscuous alleles” established by Manczinger et al.15, we can in principle hypothesize 
that selection events happening in recent times may have driven this genetic structure. Other non-promiscuous 
alleles include those of the HLA-DRB1*04 allelic group (accounting altogether for 70.22% of the total HLA-DRB1 
diversity observed in Lacandons), with some of them being associated with specific pathogens as discussed above. 
It is noteworthy that at least one allele of this allelic group has been implicated in resistance to the development 
of enteric fever caused by Salmonella enterica92 and that there is molecular evidence of this pathogen causing at 
least one outbreak after the conquest in a region not far away from Chiapas (i.e. the state of Oaxaca)93. New alleles, 
with a very specific peptide binding repertoire, might be the most efficient way to achieve resistance to specific 
pathogens, as high promiscuity may not be able to cope with the rise of novel pathogens15,94.
Figure 3. Zoom-in to the Native American cluster of the population phylogenetic tree built with 114 human 
groups (including Lacandon Mayan from this work). European populations are represented by green branches; 
African human groups correspond to yellow branches; red branches were assigned to Asian populations; 
Native American populations are represented by purple branches; populations from Oceania are indicated with 
pink branches. Our Lacandon sample is highlighted with a purple star. For a view of the complete tree, please 
refer to Supplementary Fig. 2. Argentina Gran Chaco Eastern Toba (n = 135) ArE; Argentina Gran Chaco 
Mataco Wichi (n = 49) ArM; Argentina Gran Chaco Western Toba Pilaga (n = 19) ArP; Argentina Rosario 
Toba (n = 86) ArT; Brazil Terena (n = 60) BrT; Mexico Lacandon (n = 228) Lac; Mexico Mixe (n = 55) MMx; 
Mexico Mixtec (n = 103) MMi; Mexico Seri (n = 34) MSe; Mexico Tarahumara (n = 44) MTa; Mexico Zapotec 
(n = 90) MZa; Paraguay Guarani (n = 40) Py; Peru Titikaka Lake Uro (n = 105) PeU; USA Gila River (n = 492) 
USG; USA Sioux (n = 302) USS; USA Yupik (n = 252) USY; Venezuela Yucpa (n = 73) VeY. References for all 
populations of this dataset are listed in Supplementary Table 1. For the zoom-out of this phylogenetic tree, 
please see Supplementary Fig. 2.
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Sanchez Mazas et al.6 found a positive relationship between HLA-B genetic diversity and either pathogen score 
or viral score, once distance from Africa was taken into account. In our analysis, our fitted coefficients were con-
sistent with a positive relationship, but we could not reject the null hypothesis of no relationship (Supplementary 
Tables 3 and 4). Sanchez Mazas et al. did not find evidence for a relationship between HLA-DRB1 genetic diversity 
and either pathogen score or viral score. Within our dataset, the strongest signal of any relationship (albeit one 
which was not robust to a Bonferroni correction) was for a negative relationship between HLA-DRB1 genetic 
diversity and viral score once distance from Africa is considered, in non-Native American populations. We found 
no evidence for a relationship between either distance from Africa or pathogen/viral scores and HLA diversity 
when the Native American populations were considered alone. This may be due to the small size of the dataset. 
A better picture may be drawn in the coming years when ancient DNA analyses are taken into account for study-
ing the immunogenetic diversity of these and other populations before and after specific events that would have 
Figure 4. HLA associations in the Lacandon Maya sample from SE Mexico. (A) HLA-A~B associations, (B) 
HLA-B~C associations and (C) HLA-B~DRB1 associations.
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changed the immune challenges faced by Native Americans, especially after contact with so-called Old World 
populations.
It has been shown using a multilocus model of host–pathogen co-evolution with allele-specific adap-
tive immunity that if selection from a multi-epitope, strain-structured pathogen is maintaining associations 
between host recognition loci, alleles at those loci should not only be in linkage disequilibrium, but also exhibit 
non-overlapping associations24. Penman et al.24 showed in particular that pathogen selection has the potential to 
maintain non-overlapping associations between HLA loci despite the presence of recombination between those 
loci. They demonstrated that such long-range non-overlapping associations may be observed between HLA loci 
such as HLA-B and HLA-DRB1 in a dataset of HLA haplotypes from the Hutterite population of South Dakota. 
We examined non-overlapping associations within Lacandon HLA haplotypes in an effort to identify similar 
possible signatures of pathogen selection (Figs. 3, 4 and Supplementary Fig. 3). In our dataset, the highest levels 
of non-overlap between HLA loci are observed between the physically close HLA-B and -C pair and the similarly 
physically close HLA-DRB1 and HLA-DRB3/4/5. Such associations could be a result of pathogen selection, but 
given the likely low level of recombination between these loci we cannot rule out other population genetic pro-
cesses. For HLA-DRB1 and HLA-DRB3/4/5, epistasis with the HLA-DRA locus with which the gene products of 
HLA-DRB1 or HLA-DRB3/4/5 must interact may contribute to particularly high levels of non-overlap. Recent 
work has also revealed that haplotypic associations between HLA-B and HLA-C in particular may be driven 
by the different mechanisms by which the proteins they encode are likely to be able to participate in NK cell 
education95.
There was no evidence for non-overlapping associations spanning class I and class II HLA loci in the Lacandon 
dataset, which may suggest that the most recent forms of pathogen selection in the Lacandon population have 
acted on the class I and/or class II loci separately. Furthermore, due to the particularly devastating infectious dis-
ease events the Lacandon, and other Native American populations have experienced – in which many people have 
died in large epidemics93,96–99– it is unlikely that the patterns seen in this group may be the result of the long-term 
pathogen selection simulated in the original Penman et al. model24. It may be that the Lacandon population main-
tained a set of haplotypes as a consequence of millennia of co-evolution with prevalent American pathogens, and 
the pattern seen today is the consequence of a short-term disruption of that state. It has been recently found100 
that class II genes show a signature for selection when comparing Native Americans from the same region in the 
northwest coast of North America before and after the contact with Europeans and the European-borne patho-
gens during the conquest and colonial period98,99,101. Our results further add to the discussion on whether HLA 
class II region could have been under similar selective pressure in Native Americans.
In summary, the Lacandon Maya represent one of the most homozygous and least diverse populations regard-
ing HLA class II genes among Native American populations. It is possible that a history of infections, genocides 
and inbreeding contributed to this limited diversity in the HLA system. The relationship between genetic diversity 
of the HLA system and both pathogen and viral diversity, as well as its correlation with the geographic distance 
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Figure 5. HLA ⁎fadj scores. The red crosses in panels (A–C) illustrate non-overlap measured using 
⁎fadj for 
(A) HLA-A and all other HLA loci in the Lacandon dataset; (B) HLA-B and all other HLA loci in the dataset 
and (C) HLA-DQB1 and all other HLA loci in the dataset. For each pair of loci we also generated 5000 different 
random combinations of the alleles found at each locus, and calculated ⁎fadj scores obtained from those 
randomized combinations. The ⁎fadj scores from the random combinations are shown as blue markers. These 
individual markers overlay one another at the scale used here, but illustrate the distribution of randomized 
scores. The heatmap in panel (D) indicates by how many standard deviations of the randomized ⁎fadj score 
distribution the actual ⁎fadj for a pair of loci in the Lacandon dataset exceeds the mean of the randomized 
⁎fadj 
distribution for that pair.
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from Africa, may become clearer if data from previous time periods are only considered. Future work using 
ancient DNA approaches to study populations before specific historic and prehistoric periods (e.g. the conquest 
of the Americas or great human migrations), but also identifying pathogens that caused outbreaks and epidemics, 
may shed light on the actual diversity of the HLA system in human populations before and after epidemic and 
pandemic events that may have shaped the immunogenetic diversity of our species.
Subjects and Methods
Subjects. A total of 218 first-degree non-related Lacandon individuals [146 ♀ (64.2%) and 82 ♂ (35.8%); aver-
age age = 31.7 ± 17.4 years] were studied for a final number of 436 chromosomes. All participants were inhab-
itants from small villages located in the Lacandon jungle in the southern State of Chiapas, Mexico including: 
Lacanjá, Bethel, E. Lacandón, Metzabok, Na Há, San Javier, and Tumbo, all of them belonging to the municipality 
of Ocosingo (Fig. 1). We confirmed the Lacandon ancestry (parents and grandparents born in the same region) 
of all included individuals by questionnaire. Collection of blood samples and demographic data was performed 
according to the requisites of the Helsinki Declaration (2008) and the General Health Law of Mexico and follow-
ing the protocol approved jointly by the Ethics in Research Committee and the Research Committee from the 
National Institute for Medical Sciences and Nutrition “Salvador Zubirán” (INCMNSZ). All subjects provided 
written informed consent for these studies, and they authorized the storage of their DNA samples. Informed 
consent was obtained from all participants. When participants were under 18 years at the time of the sample 
collection, informed consent was obtained from a parent and/or legal guardian.
High resolution HLA typing by next generation sequencing. Genomic DNA was obtained from 
peripheral blood mononuclear cells using the QIAamp DNA mini kit (Qiagen®, Valencia, CA, USA). All samples 
were typed for 11 HLA loci utilizing low- and high-resolution methods. Low resolution typing was performed by 
a Luminex-based detection and typing method including PCR amplification and reverse oligonucleotide hybrid-
ization (LABType® SSO Typing Tests, One Lambda Inc., Canoga Park, CA, USA). High-resolution HLA class I 
and class II typing was performed by a recently developed high throughput sequencing technique involving long 
range PCR of each HLA locus, shearing of DNA and high throughput NGS typing as previously described102. In 
addition, these samples were typed with a commercial kit MIA FORATM NGS FLEX HLA Typing Kit (Immucor, 
Norcross, GA, USA) that utilizes a similar method which applies enzymatic fragmentation instead of Covaris 
Figure 6. Worldwide distribution of pathogen and viral richness and genetic diversity for HLA. (A) Pathogen 
richness; (B) Viral richness; (C) HLA-B genetic diversity as estimated with polymorphism informative content 
(PIC) as a proxy for HLA class I diversity; HLA-DRB1 genetic diversity as estimated with PIC as a proxy for 
HLA class II diversity.
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sonication. HLA genotypes were assigned utilizing the ad hoc MIA FORA software HT9v1 (Immucor, Norcross, 
GA, USA), provided by the manufacturer with the reference sequence ver. 3.2.25 of the IMGT-HLA database103. 
The HLA typing system we used covers the class I genes in their full sequence. With exception of HLA-DPB1, 
the class II loci were covered in their full sequence. The sequence fragments (at least 300 bases long each) were 
put in phase. Given the number of SNPs, we could put in phase the sequences of almost all alleles. There were no 
ambiguities in the class I or class II loci with exception of HLA-DPB1. We had virtually no ambiguities in DPB1 
because more than 65 percent of the subjects were homozygous in DPB1 resulting from the high frequency 
of DPB1*04:02 alleles (the frequency for DPB1*04:02:01:01 and DPB1*04:02:01:02 was ≥0.8). Among the few 
ambiguities observed, all of them resulted from genotypes that include alleles with identical sequences in exon-2 
that differ in exon-3 and cannot be placed in phase because of lack of informative SNPs. Almost all ambiguous 
HLA-DPB1 genotypes (<2%) included DPB1*04:02; we assigned the likely genotype as the one including this 
allele. In summary, there were no ambiguities for all loci with exception of HLA-DPB1; the rate of ambiguity at 
HLA-DPB1 was low because of low allelic diversity at this locus in this population; the most likely genotype was 
assigned on the basis of allele distributions in unambiguous genotypes.
HLA blocks and haplotypes assignment. HLA allele and haplotype frequencies were obtained by gene 
counting; seventy of the 458 haplotypes were obtained by family segregation analysis, since they were obtained 
by HLA typing of 69 individuals from 36 known families (related individuals were excluded to avoid overrep-
resentation of alleles and haplotypes). In 160 individuals without available samples from close family members, 
frequencies for alleles, two-point, three-point, four-point and five-point associations were determined using 
direct counting using the computer program Arlequin ver. 3.5104 and further corroborated with Hapl-o-Mat105 
using an Expectation-Maximization (EM) algorithm. Arlequin was also used to calculate HWE, OH and EH 
at a locus-by-locus level with 1 × 106 steps in the Markov chain; p-values ≤ 0.05 indicated statistical differ-
ence between OH and EH and thus a deviation from HWE and confirmed with an independent analysis done 
with PyPop106 ver. 0.7.0 using the Ewens-Watterson homozygosity (EWH) test of neutrality (tested by Slatkin’s 
implementation of the Monte-Carlo approximation of the Ewens-Watterson exact test). Listed HLA-B~C, 
HLA-DRB1~DQB1, HLA-DRB1~DRB3/4/5, HLA-DQB1~DQA1, HLA-DPB1~DPA1, Class I and Class II blocks, 
conserved extended haplotypes (HLA-B~C~DRB1~DQB1) and their extension to the HLA-A locus were esti-
mated by maximum likelihood methods based on the standardized delta (Δ′) between alleles of two loci and 
between the two blocks and/or the extension to the HLA-A region, as previously described72,107. Estimation of 
delta (Δ) and standardized delta (Δ′) values to measure linkage disequilibrium (LD), nonrandom association 
of alleles at two or more loci, and their statistical significance, were calculated using previously described meth-
ods23,107. We used the statistic parameter t to validate all Δ′ data adjusted by sample size and number of times that 
each allele appeared in the sample72,108. Only t values ≥ 2.0 were considered significant. Most probable ancestry 
(MPA) for each haplotype was determined based on the relative frequencies of the haplotypes in well-defined 
continental populations. Based on previously published approaches109, haplotypes regarded as Native American 
MPA were defined as those found in significant frequencies (H.F. ≥ 1.0%) in Native American populations 
such as Argentina Gran Chaco Eastern Toba, Xavantes from Central Brazil64, South or Central America Native 
Americans70, Yucpa from Venezuela35, Aleut from Bering Island70,110, Penutian from British Columbia111, 
Tarahumaras from Northern Mexico26, Mixe, Mixtec and Zapotec from Oaxaca State, Southern Mexico29,32, North 
American Natives107 from USA, and Yup’ik112 from USA. European MPA haplotypes were defined as those pres-
ent in significant frequencies (H.F. ≥ 1.0%) in European human groups such as Bosnia and Herzegovina [from the 
Deutsche Knochenmarkspenderdatei (DKMS), Germany], Greece (from the DKMS), Croatia (from the DKMS), 
Romania (from the DKMS), Spain (from the DKMS)71, Italy78, Gorski Kotar from Croatia113, Northern Ireland114 
and Ireland115. Haplotypes of African MPA were defined as those found in significant frequencies (H.F. ≥ 1.0%) 
in African or African-descent human groups such as Azoreans from Terceira Islands (data collected by Jacome 
Bruges Armas, available in61), USA African American73, Bandiagara from Mali79,116, Kampala from Republic of 
Uganda79,117, Nandi from Kenya79 and Zambians79,118. Asian MPA haplotypes were found in H.F. above 1.0% in 
Asian human groups like Nganasan and Ket from Lower Yenisey River/Taimyr Peninsula region (Siberia)119, 
Chinese (from the DKMS)71, Taiwanese120, Japanese69, Ivatan from Bantanes, Republic of the Philippines121, and 
Koreans122. Mixed-ancestry populations included USA70,73 and Mexican72 well-defined mixed ancestry human 
groups. With these results, we calculated the aggregate block frequency (ABF)17,123,124 for each ancestry for class 
I, class II and CEHs.
Analysis of HLA genetic diversity and non-overlapping associations between HLA loci. The 
genetic diversity of each HLA locus was assessed by two previously described forensic parameters: PIC and 
PD125,126; computed using the PowerStat ver.1.2 spreadsheet (Promega Corporation, Fitchburg, WI, USA) as 
described previously72. PIC measures the strength of a genetic marker for linkage studies by indicating the degree 
of polymorphism of a locus. PIC > 0.5 is considered as highly polymorphic125. PD is defined as the probability 
of finding two random individuals with different genotypes for that locus in the studied population, and values 
higher than 0.8 indicate high polymorphism in the studied population context126.
Penman et al. have argued that certain types of non-overlapping association between HLA loci may be a sig-
nature of pathogen selection24. The previously developed ⁎fadj metric
24,127 was calculated for each pairwise combi-
nation of HLA loci in the dataset, using 436 Lacandon haplotypes for which we had data for every HLA locus. 
Penman et al. used ⁎fadj to compare patterns of non-overlap between HLA-HLA pairs and HLA-non HLA pairs of 
loci. In the current study we have only data on Lacandon HLA loci. In order to provide a point of comparison for 
the ⁎fadj score of each locus pair we generated 5000 random permutations of the order of the 436 alleles at one of 
the loci in each pair, and re-calculated ⁎fadj for each set of randomized data We thus generated distributions of 
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possible ⁎fadj scores for each pair of loci in the dataset that would be obtained if the alleles at those loci were asso-
ciated entirely at random. We then calculated the difference between the ⁎fadj value calculated from the Lacandon 
dataset for each pair of loci and the mean of the ⁎fadj scores calculated from the randomized data for that pair of 
loci, then divided that difference by the standard deviation of ⁎fadj calculated from the randomized data. The 
resulting scores allowed us to rank the HLA pairs in order of how extreme a level of non-overlap they displayed 
relative to entirely random associations between the same alleles. There are many reasons why associations 
between HLA loci should not be entirely random, so we do not claim that a departure from randomness neces-
sarily means selection has occurred. However, ranking the pairs of HLA loci by how much they each depart from 
a state of random association allows for a more meaningful assessment of which pairs of HLA loci are most 
strongly non-overlapping, since it accounts for the differing allelic diversity at each locus.
Analyzing genetic relationships between populations. A PCA plot and a population phylogenetic 
tree were constructed for 180 populations (including the Lacandon group studied in this work) with HLA-A, 
HLA-B and HLA-DRB1 low-resolution data from a worldwide population dataset (Supplementary Table 1) using 
the IBM SPSS Statistics 19 software (IBM Corporation, Armonk, NY, USA) for the PCA and POPTREEW128 to 
analyze the distribution of 115 human groups with high resolution HLA typing, including our Lacandon sample. 
We used DA distance129 and a NJ clustering method to construct a population phylogenetic tree with bootstrap-
ping (1200 replications). References for each population group included in the PCA and phylogenetic analysis are 
listed given in Supplementary Table 1.
Assessment of the correlation between pathogen richness and HLA diversity. We used PIC as 
an estimator for genetic diversity for three HLA loci (HLA-A, HLA-B and HLA-DRB1) and conducted an analysis 
of HLA genetic diversity and pathogen species richness similar to that of Sanchez-Mazas et al.6. First, we tested 
the correlation between genetic diversity for each gene and the geographic distance from Africa. We maintained 
the five key geographic points suggested by the authors and modeled the distance (in Km) from Addis Ababa (as 
a suggested point of departure) to every one of the locations where the 122 populations analyzed in the previous 
point (with available high-resolution data) live today. In our dataset the same populations were used for the three 
genes analyzed. Distance was calculated with the Measure distance function of Google Maps130. Information on 
pathogen and viral richness was extracted from the GIDEON database57. In order to relate the level of HLA pol-
ymorphism within a population and the pathogen environment of this population, we compiled the number of 
infectious diseases present in all countries for which we had information on HLA genetic diversity (N = 115). To 
assess the effect of genetic drift/recent bottlenecks/selection on small sized, isolated populations, we ran the sta-
tistical analyses after excluding Native American populations, and also ran tests on Native American populations 
separately. The final datasets include, thus, the worldwide populations’ dataset, the Native American populations’ 
dataset and the worldwide non-Native American populations’ dataset.
We used general linear models to determine how the distance from Africa and either pathogen or viral rich-
ness explained the level of genetic diversity (as estimated with PIC) at each of the three loci, for each of the data-
sets previously listed. We logit-transformed the PIC values before carrying out the analyses in order to improve 
normality. Coefficients for the relationships between distance, pathogen score or virus score; their 95% confi-
dence intervals and associated p values, and the R2 value for each model are shown in Supplementary Tables 3 
and 4. We performed the analyses with and without outliers. Outliers were defined as populations for which the 
logit transformed PIC value at any of the three loci was further than 2 standard deviations away from the mean 
logit(PIC) value for that locus.
Data availability
All data from our sample sets, both frequencies and anonymized individual genotypes, can be found at The Allele 
Frequency Net Database website (www.allelefrequencies.net)131 (AFDN Population ID: 3666). Sequence data 
can be found at the European Nucleotide Archive under accession numbers: KU319387, KU233196, KU319386, 
KU319291, KU319274, KU319273, KU319277, KU319263, KU319282, KX825916, KU319262, KU319256, 
KU319255, KU319285, KU319287, KU319303, KU319304, KU319325, KU319272, and KX825915. Further 
information can be requested to J.G. and/or M.F.V.
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